Penny Stock Tripled in 3 Months; Board Announced Bonus Shares in 3:1 Ratio

Shukra Pharmaceuticals Limited (BSE: 524632) has recently announced to give bonus shares to its investors, after which the shares of the company are seeing a rise, back-to-back upper circuits are going on and the shares of the company have doubled in just one month.

A lower circuit of 5% was seen in its shares on the last trading day on Thursday, March 7, 2024, and the shares are trading at Rs 381.30. Its 52-week high is Rs 388.30 and its 52-week low is Rs 41.76.

Board Announced Bonus Shares in 3:1 Ratio

The company has proposed to issue bonus shares to its existing shareholders in the ratio of 3:1, which means the existing shareholders will get 3 bonus shares for every 1 share they hold. The current face value of the share is Rs. 10/- each, which will be of the same value after the bonus is given.

However, no record date has been announced yet for giving the bonus. The board of directors of the company says that the company will announce the record date soon after getting approval from all the parties or members of the company through a postal ballot.

Company Reported Positive Results

Figures in Rs. Crores

In Q3FY24, the companies’ net sales grew by 721% to Rs 18.89 crore compared to Rs 2.30 crore in Q3FY23, and net profit grew over 300 times to Rs 9.42 crore compared to Rs 0.03 crore in Q3FY23.

Shukra Pharmaceuticals Shares Performance & Return

Shukra Pharmaceuticals Limited was listed on BSE in Apr 2015 and since its listing, it has delivered good returns. This stock has given a 128.27% return in a month, 152.73% in two months, and 228.96% in three months. You can check the tables below to know the performance in detail.

Shukra Pharmaceuticals Shares Zoom 600% in Just 1 Year

The company’s overall performance over the last 12 months is 598.13% and for investors who invested ₹1 lakh in it 12 months ago, its value has grown to ₹698,132 today.

Shukra Pharmaceuticals Stock UP 190% in 2024 YTD

Shukra Pharmaceuticals share price was ₹121.30 in January and today it is trading at ₹351.30 in BSE, representing a total gain of 189.61% in 2024 YTD.

Shukra Pharmaceuticals Shares Surged 350 Percent in 2023

Investors who invested in it in 2023 earned quite well returns. The share price of Shukra Pharmaceuticals in January 2023 was ₹27.54 and on the last trading day of the year, it closed at ₹123.75 with a gain of 349.35%

Shukra Pharmaceuticals Share Performance (Compounding)

In the table below, you can check the company’s absolute returns and CAGR growth from listing. You can also check that if someone has invested a lump sum of Rs 1 lakh, then what is the value of those shares today…

• If we look at the performance of the last 12 months, it has seen a rise of 600 percent.
• In the last two years, it has increased investors’ money by more than 25 times.
• For investors who had invested Rs 1 lakh in Shukra Pharmaceuticals’ Shares five years ago, the value of those ₹1 lakh worth of shares has increased to ₹61.2 lakh today.
• The company’s last five-year stock CAGR growth is 127.69% and since the listing is 47.53%.

Shukra Pharmaceuticals Share Performance (Year-wise)

About the Company

Established in 1993, Shukra Pharmaceuticals Limited is engaged in the pharmaceutical industry, specializing in manufacturing and trading a variety of Pharmaceutical Products and laboratory testing. With a broad product portfolio encompassing antibiotics, anti-fungal agents, sedatives, vitamins, and much more, the company has consistently provided quality healthcare solutions.

Shukra Pharmaceuticals Profit & Loss Statement

Figures in Rs. Crores

Last 10 Years Compounded Sales & Profit Growth

Shukra Pharmaceuticals Shareholding Pattern

Disclaimer: This article is for informational purposes only and should not be considered investment advice.